ARTICLE | Finance

3Q Financial Markets Review: Watching funds flow

October 1, 2001 7:00 AM UTC

Blinders often are used on race horses to keep the animals focused on the race at hand, and away from the distractions and chaos going on around them. Biotech CEOs and investors probably wouldn't be faulted for wanting a similar technology that could keep them focused on the end game.

While it can be disheartening that fundamentals go unrewarded in the current market, there's a growing consensus that when - not if - the markets return, biotech will be quick off of the bottom. This reflects both the industry's fundamental progress and - ironically, given biotech's historical volatility - investors looking for safe places to park their money...